Breast cancer, affecting primarily women, is one of the most common cancers with increasing survival rates, yet treatment remains an area for improvement.1 As of 2019, female breast cancer has the highest rates of new diagnoses and is the second highest in number of cancer-related deaths in ...
Last year, results from the phase 3TH3RESA trial, which were presented at the European Cancer Congress, showed that T-DM1 nearly doubled progression-free survival, compared with the physician's choice of treatment. The 602 participants in that trial had advanced metastatic disease and had alread...
Chlorella is used in the treatment of many ailments including fibromyalgia and chronic fatigue syndrome. Do not take chlorella if you are pregnant or breastfeeding. Common side effects of chlorella include diarrhea, green color stools, stomach cramping, nausea, gas (flatulence), skin sensitivity to...
Myongji Hospital said it has replaced its radiation cancer treatment machine with VitalBeam, the latest linear accelerator. Myongji Hospital Chairman Lee Wang-jun (seventh from right) cuts the ribbon with other hospital staff to celebrate the installment of VitalBeam, the newest linear accelerator, wit...
Treatment options for renal cell carcinoma (RCC) have multiplied in the past 5 years. Pazopanib is the third tyrosine kinase inhibitor (TKI) and the sixth targeted therapy that has received US FDA approval for the treatment of advanced or metastatic RCC. The primary mechanism of action of pazop...
ASHP Midyear: New Oral Treatment, Antibody Drug Conjugates Offer Additional Options for Breast Cancer ASHP Midyear: Compounding Medications Provide Personalized Options for Patients ASHP Midyear: Real-World Data Collection Helps to Facilitate Successful Biosimilar Adoption Public Health Matters Video: The...
Published in theJournal of Neuroimmunology, the preliminary research is believed to be among the first studies to look at cancer patients in active treatment and whether inflammation is involved in their chemo-brain symptoms. Results showed that among 22 breastcancer patientstaking chemotherapy, those ...
The use of adjuvant endocrine therapy in the treatment of hormone receptor-positive, early breast cancer has become important in both pre- and postmenopaus... RW Carlson,IC Henderson - 《Breast Cancer Research & Treatment》 被引量: 32发表: 2003年 Phase II, randomized, placebo-controlled study...
Breast Cancer Research and Treatment 2012;133:237-46.KUTER I, GEE J M, HEGG R, et al. Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized phase Ⅱ study[J]. Breast Cancer Res Treat, 2012, 133(1): 237-246....
Cone launched its Breast Cancer Awareness Collection with a nod to pink, partnering with the Alight Program, which provides financial, educational, and emotional support to women and families navigating diagnosis and treatment. Secondly, Cone released its Pride Selvage Community ...